STRO

STRO

USD

Sutro Biopharma Inc. Common Stock

$1.100+0.000 (0.000%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$1.100

High

$1.110

Low

$1.030

Volume

0.07M

Company Fundamentals

Market Cap

92.2M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.85M

Exchange

NGM

Currency

USD

52-Week Range

Low $0.52Current $1.100High $5.17

Related News

GlobeNewswire

Sutro Biopharma to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

View more
Sutro Biopharma to Participate in Upcoming Investor Conferences
PR Newswire

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty

Equity Insider News Commentary – Optimism in the field of oncology is on the rise, thanks to the National Institutes of Health's latest annual...

View more
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target

HC Wainwright & Co. analyst Andres Maldonado reiterates Sutro Biopharma with a Neutral and maintains $2 price target.

View more
HC Wainwright & Co. Reiterates Neutral on Sutro Biopharma, Maintains $2 Price Target
GlobeNewswire

Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025

SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),

View more
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025